Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD

Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD

Use of systemic corticosteroids for the treatment for coronavirus disease 2019 (COVID-19) among chronic obstructive pulmonary disease (COPD) patients is not well described. A 58-year-old man with fever and progressive dyspnea was admitted to the Showa University Hospital, and showed severe respirato...

Full description

Bibliographic Details
Main Authors: Hideki Inoue, Megumi Jinno, Shin Ohta, Yasunari Kishino, Tomoko Kawahara, Hatsuko Mikuni, Haruna Sato, Mayumi Yamamoto, Yoko Sato, Chisato Onitsuka, Yuiko Goto, Hitoshi Ikeda, Hiroki Sato, Tomoki Uno, Yoshitaka Uchida, Tomoyuki Kimura, Yoshito Miyata, Kuniaki Hirai, Tetsuya Homma, Yoshio Watanabe, Sojiro Kusumoto, Shintaro Suzuki, Issei Tokimatsu, Akihiko Tanaka, Hironori Sagara
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Subjects:
COVID-19
SARS-CoV-2
COPD
Favipiravir
Systemic corticosteroid
Pneumonia
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007120304147

Similar Items

Similar Items